Form 8-K - Current report:
SEC Accession No. 0001641172-25-007944
Filing Date
2025-05-01
Accepted
2025-04-30 19:31:33
Documents
18
Period of Report
2025-04-25
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45419
2 EX-99.1 ex99-1.htm EX-99.1 3219
3 GRAPHIC ex99-1_001.jpg GRAPHIC 1503842
4 GRAPHIC ex99-1_002.jpg GRAPHIC 1889881
5 GRAPHIC ex99-1_003.jpg GRAPHIC 932870
  Complete submission text file 0001641172-25-007944.txt   6174223

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE idxg-20250425.xsd EX-101.SCH 3018
7 XBRL LABEL FILE idxg-20250425_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE idxg-20250425_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3476
Mailing Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054
Business Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

EIN.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24249 | Film No.: 25898666
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)